KRAS and neoplasm: It was also shown that tumor cells that were treated with specific G12C inhibitors had an initial suppression of the MAPK pathway, but afterwards adapted by activating wild RAS, thus despite continuous inhibition of GTP-bound KRAS, the MAPK pathway is reactivated within 24–48 hours [35].